US-based manufacturer of polymer-based delivery system technologies and formulations Skinvisible Inc has agreed to merge with Quoin Pharmaceuticals Limited.

Quoin Pharmaceuticals develops products to address societal issues such as opioid epidemic and military veteran suicide rate.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Quoin shareholders will hold 72.5% and Skinvisible shareholders will hold 27.5% stake in the newly formed firm Quoin Pharmaceuticals Inc.

“Quoin shareholders will hold 72.5% and Skinvisible shareholders will hold 27.5% stake in the newly formed firm Quoin Pharmaceuticals Inc.”

Avista Capital Partners has agreed to acquire United BioSource Corp (UBC), a company based in the US, from Express Scripts Holding Co for an undisclosed sum.

Also based in the US, UBC is a healthcare company that offers pharmaceutical support services.

The acquired company is a private equity firm that intends to strengthen its footprint in the healthcare sector through the acquisition.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact